As the Head of the Liver Carcinogenesis Section, he leads a basic and translational research laboratory focused on using molecular techniques to classify tumor subtypes, identify biomarkers for early detection, diagnosis, prognosis, and treatment response, and uncover the molecular mechanisms driving liver cancer, with the goal of advancing prec...

Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. K Forrester, S Ambs, SE Lupold, RB Kapust, EA Spillare, WC Weinberg, ...

2024年12月12日 · In 2023, Dr. Wang was appointed as Deputy Director of the Center for Cancer Research (CCR) at NCI. Dr. Wang's laboratory utilizes advanced technologies to investigate primary liver cancer. He has led several major international research initiatives on liver cancer genomics, collaborating with multiple universities and cancer centers globally.

Xin Wei Wang is a Senior Investigator at the US National Cancer Institute (NCI) where he directs a research lab studying liver cancer. He also serves as Deputy Chief of the Laboratory of Human Carcinogenesis and Co-Director of the Liver Cancer Program, Center for Cancer Research, NCI in Bethesda, Maryland.

2016年4月21日 · 王心伟博士（ Dr. Xin Wei Wang ）现为美国国家癌症研究所资深研究员，人类癌发研究实验室副主任。 王心伟博士1991年获纽约大学博士学位，1998年被美国国家癌症研究所聘为研究员，2005年晋升为资深研究员。

As a senior investigator, Dr. Wang's research centers on the functional genomics of liver cancer, utilizing genome-wide technologies in conjunction with national and international collaborations and clinical studies.

Xin Wei Wang, PhD, a Senior Investigator, Co-Director of the NCI CCR Liver Cancer Program, Deputy Lab Chief of the NCI CCR Laboratory of Human Carcinogenesis; a world-renowned cancer biologist with a special focus on functional genomics of liver cancer using genome-scale technologies paired with several international collaborative initiatives an...

Xin Wei Wang PhD NCI, National Institutes of Health As Senior Investigator at the National Cancer Institute (NCI), Dr. Wang has dedicated his professional life on improving early detection, diagnosis and treatment of liver cancer for over 25 years.